HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Online Discussion Correction (v70,p1765) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Olaf Wendler Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lausberg, H. F. Articles by Schäfers, H.-J. Search for Related Content PubMed PubMed Citation Articles by Lausberg, H. F. Articles by Schäfers, H.-J. Related Collections Related Article

Ann Thorac Surg 2000;70:367-371
© 2000 The Society of Thoracic Surgeons

---

Original articles: general thoracic

Bronchial and bronchovascular sleeve resection for treatment of central lung tumors

^a Departments of Thoracic and Cardiovascular Surgery, University Hospitals Homburg, Homburg/Saar, Germany
^b Departments of Pneumology and Internal Medicine, University Hospitals Homburg, Homburg/Saar, Germany

Address reprint requests to Dr Schäfers, Department of Thoracic and Cardiovascular Surgery, University Hospitals Homburg, Kirrberger Str 1, 66421 Homburg/Saar, Germany
e-mail: chhjsc{at}med-rz.uni-saarland.de

Presented at the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31–Feb 2, 2000.

Background. To improve postoperative pulmonary reserve, we have employed parenchyma-sparing resections for central lung tumors irrespective of pulmonary function. The results of lobectomy, pneumonectomy, and sleeve resection were analyzed retrospectively.

Methods. From October 1995 to June 1999, 422 typical lung resections were performed for lung cancer. Of these, 301 were lobectomies (group I), 81 were sleeve resections (group II), and 40 were pneumonectomies (group III).

Results. Operative mortality was 2% in group I, 1.2% in group II, and 7.5% in group III (group I and II vs group III, p < 0.03). Mean time of intubation was 1.0 ± 4.1 days in group I, 0.9 ± 1.3 days in group II, and 3.6 ± 11.2 days in group III (groups I and II vs group III, p < 0.01). The incidence of bronchial complications was 1.3% in group I, none in group II, and 7.5% in group III (group I and II vs group III, p < 0.001). After 2 years, survival was 64% in group I, 61.9% in group II, and 56.1% in group III (p = NS). Freedom from local disease recurrence was 92.1% in group I, 95.7% in group II, and 90.9% in group III after 2 years (p = NS).

Conclusions. Sleeve resection is a useful surgical option for the treatment of central lung tumors, thus avoiding pneumonectomy with its associated risks. Morbidity, early mortality, long-term survival, and recurrence of disease after sleeve resection are similar to those seen after lobectomy.

Related Article

Discussion
Ann. Thorac. Surg. 2000 70: 371-372. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				P. N. Chhajed, R. Eberhardt, H. Dienemann, A. Azzola, M. H. Brutsche, M. Tamm, and F. J.F. Herth Therapeutic bronchoscopy interventions before surgical resection of lung cancer. Ann. Thorac. Surg., May 1, 2006; 81(5): 1839 - 1843. [Abstract] [Full Text] [PDF]

				S.-i. Takeda, H. Maeda, M. Koma, Y. Matsubara, N. Sawabata, M. Inoue, T. Tokunaga, and M. Ohta Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer.: Trends over time and 20-year institutional experience Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 276 - 280. [Abstract] [Full Text] [PDF]

				H. F. Lausberg, T. P. Graeter, D. Tscholl, O. Wendler, and H.-J. Schafers Bronchovascular Versus Bronchial Sleeve Resection for Central Lung Tumors Ann. Thorac. Surg., April 1, 2005; 79(4): 1147 - 1152. [Abstract] [Full Text] [PDF]

				C. Ludwig, E. Stoelben, M. Olschewski, and J. Hasse Comparison of Morbidity, 30-Day Mortality, and Long-Term Survival After Pneumonectomy and Sleeve Lobectomy For Non-Small Cell Lung Carcinoma Ann. Thorac. Surg., March 1, 2005; 79(3): 968 - 973. [Abstract] [Full Text] [PDF]

				D. Hellwig, T. P. Graeter, D. Ukena, T. Georg, C.-M. Kirsch, and H.-J. Schafers Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma J. Thorac. Cardiovasc. Surg., December 1, 2004; 128(6): 892 - 899. [Abstract] [Full Text] [PDF]

				M. K. Ferguson and A. G. Lehman Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques Ann. Thorac. Surg., December 1, 2003; 76(6): 1782 - 1788. [Abstract] [Full Text] [PDF]

				G. Varela, M. F. Jimenez, N. Novoa, and P. Macri Discordance between predicted postoperative forced expiratory volumes in one second (ppoFEV1) calculated before and after resection of bronchogenic carcinoma Interactive CardioVascular and Thoracic Surgery, June 1, 2003; 2(2): 138 - 142. [Abstract] [Full Text] [PDF]

				A. Terzi, A. Lonardoni, G. Falezza, G. Furlan, P. Scanagatta, F. Pasini, and F. Calabro Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 888 - 893. [Abstract] [Full Text] [PDF]

				A.E. Martin-Ucar, N. Chaudhuri, J.G. Edwards, and D.A. Waller Can pneumonectomy for non-small cell lung cancer be avoided? An audit of parenchymal sparing lung surgery Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 601 - 605. [Abstract] [Full Text] [PDF]

				P. Thomas, C. Doddoli, X. Thirion, O. Ghez, M.-J. Payan-Defais, R. Giudicelli, and P. Fuentes Stage I non-small cell lung cancer: a pragmatic approach to prognosis after complete resection Ann. Thorac. Surg., April 1, 2002; 73(4): 1065 - 1070. [Abstract] [Full Text] [PDF]